000 | 01348 a2200361 4500 | ||
---|---|---|---|
005 | 20250511231923.0 | ||
264 | 0 | _c19910125 | |
008 | 199101s 0 0 eng d | ||
022 | _a0002-9440 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDiamond, J R | |
245 | 0 | 0 |
_aIrreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. _h[electronic resource] |
260 |
_bThe American journal of pathology _cDec 1990 |
||
300 |
_a1323-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aEnalapril _xpharmacology |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 |
_aKidney _xpathology |
650 | 0 | 4 |
_aKidney Tubules _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
650 | 0 | 4 |
_aProteinuria _xchemically induced |
650 | 0 | 4 | _aPuromycin Aminonucleoside |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
700 | 1 | _aAnderson, S | |
773 | 0 |
_tThe American journal of pathology _gvol. 137 _gno. 6 _gp. 1323-32 |
|
999 |
_c2266710 _d2266710 |